Since the change of the team in February last year, Zhongheng Group has performed well. It has made drastic reforms internally, frequently launched layouts abroad, and is determined to look for new ideas and change.

A series of actions followed. Starting from the big changes in the top management, the personnel also ushered in a wave of major adjustments. A group of young cadres after 80 and 90 were promoted and reused. Since then, the organization has undergone major reforms, management efficiency has been greatly improved, and the pace of capital operation has accelerated. U.S. pharmaceutical industry is in the bag. Especially after the outbreak of New Coronary Pneumonia, Zhongheng Group quickly entered the medical protection industry and built a national-level medical protection material production and guarantee base, which further demonstrated this determination.

Successive moves have only one purpose, which is to create a "new Zhongheng".

This positive signal has already been captured by the market, but from the perspective of stock prices, everyone's attitude towards this change is still somewhat uncertain. Whether it will succeed or not depends on the final "curative effect".

But it is undeniable that the changes have already taken place and the break is on the agenda.